Robert Rapaport, MD Email Robert Rapaport
- PROFESSOR | Pediatrics, Endocrinology and Diabetes
- Pediatric Endocrinology
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Queens
- Mount Sinai Beth Israel
- Mount Sinai St. Luke's and Mount Sinai West
- Annenberg Building 212-241-6936 212-241-6936
Book an Appointment - Robert Rapaport, MD
Dr. Robert Rapaport is Professor of Pediatrics and the Chief of the Division of Pediatric Endocrinology and Diabetes in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis Children’s Hospital. He is also the Emma Elizabeth Sullivan Professor of Pediatric Endocrinology and Diabetes. Dr. Rapaport received his medical degree from State University of New York - Downstate Medical Center, training in Pediatrics at Schneider's Children's Hospital (Long Island Jewish Hospital - Hillside Medical Center) and his fellowship training in Pediatric Endocrinology at St. Christopher's Hospital for Children, Philadelphia and New York Hospital-Cornell Medical Center, New York. He has published numerous articles and chapters including chapters in major Pediatric (Nelson) and Pediatric Endocrinology (Sperling, Lifshitz and Pescovitz) textbooks. Dr. Rapaport’s current research interests include growth and growth hormone in children born SGA, neonatal thyroid disease, growth hormone-immune interactions, aspects of childhood diabetes and pubertal disorders.
American Board of Pediatrics
- Autoimmune Hypothyroidism
- Congenital Adrenal Hyperplasia
- Congenital Hypothyroidism
- Delayed Puberty
- Graves Disease
- Growth Failure
- Growth Hormone Deficiency
- Hypogonadotropic Hypogonadism
- Kleinfelter Syndrome
- Polycystic Ovary Syndrome
- Prader-Willi Syndrome
- Precocious Puberty
- Turner Syndrome
- Type 1 Diabetes
- Type 2 Diabetes
MD, S.U.N.Y., Health Science Center
Long Island Jewish Medical Center
Fellowship, Pediatric Endocrinology
St. Christopher's Hosp. for Child.
Fellowship, Pediatric Endocrinology
New York Hospital Cornell University Med Ctr
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Rapaport during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Ferring Pharmaceuticals
- Novo Nordisk
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.